Form4insider filings, from the source

SEC Form 4 · accession 0001055726-17-000008

INOVIO PHARMACEUTICALS, INC. · INO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jong Joseph Kim
Officer — Chief Executive Officer · Director
Period of report
Mar 9, 2017
Accepted (ET)
Mar 13, 2017 · 5:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 9, 2017M57,334—A2,021,944D
Common StockMar 9, 2017F17,787$6.61D2,004,157D
Common StockF2Mar 10, 2017M139,745—A2,143,902D
Common StockMar 10, 2017F52,605$6.68D2,091,297D
Common Stockholding———1,750,000IBy Family Limited Partnership
Common Stockholding———33,563IBy Daughter: EK
Common Stockholding———33,775IBy Son: JK1
Common Stockholding———5,975IBy Spouse
Common Stockholding———33,533IBy Son: JK2

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitF1—Mar 9, 2017M57,334D——Common Stock57,334114,666D
Common Stock OptionF3$6.68Mar 10, 2017A43,150AMar 10, 2017Mar 10, 2027Common Stock43,15043,150D
Restricted Stock UnitF4—Mar 10, 2017A317,100A——Common Stock317,100317,100D

Explanation of responses